Peptides and oligonucleotides - The risk of narrow protection

[naam]

A growing number of biotechnology inventions relate to peptides, oligonucleotides and other small molecules that could be used in therapeutic applications. Caroline Pallard explains the challenges of patenting such inventions. Please click here to read the article published in Life Sciences Intellectual Property Review 2010.

We hope you will enjoy reading the article. And if any questions might come up or if you would like to comment on the topic, you are most welcome to e-mail us at publicrelations@octrooibureau.nl.

With kind regards,

Nederlandsch Octrooibureau